Tango Therapeutics Funding: $225M Raised, Series A (2025)
Tango Therapeutics is based in Boston, Massachusetts. It has raised $225M in total funding. Latest round: Series A.
Tango Therapeutics funding overview
Tango Therapeutics is based in Boston, Massachusetts. Tango Therapeutics has raised $225M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in October 2025. The round record for Tango Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Farallon Capital Management, TCGX, Balyasny Asset Management, Woodline Partners LP, Nextech, Invus and 5 others. 11 distinct backers are named across the disclosed rounds.
Tango Therapeutics at a glance
Total raised
$225M
Latest round
Series A
Latest round date
October 2025
Headquarters
Boston, Massachusetts
Notable investors
Farallon Capital Management, TCGX, Balyasny Asset Management, Woodline Partners LP, Nextech, Invus, Adage Capital Management LP, Boxer Capital Management
Frequently asked about Tango Therapeutics funding
How much has Tango Therapeutics raised?
Tango Therapeutics has raised $225M in total disclosed funding across the rounds on record.
Who has invested in Tango Therapeutics?
Farallon Capital Management, TCGX, Balyasny Asset Management, Woodline Partners LP, Nextech, Invus are named among the investors backing Tango Therapeutics.
What was the latest Tango Therapeutics funding round?
The most recent disclosed round is a Series A, announced in October 2025.
Where is Tango Therapeutics based?
Tango Therapeutics is based in Boston, Massachusetts.
When did Tango Therapeutics last raise?
The last disclosed Tango Therapeutics round closed in October 2025 at Series A.
Totals shown for Tango Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.
